Fundraising Fox

Rodger Novak

Investor

Venture Partner at SR One Capital Management

Switzerland

Writes $500K – $5M checks · typically $2.8M

Experience

  1. AIRNAChair of the Board of Directorscurrent2023 — presentTübingen, Germany & Boston, USA
  2. Econic BiosciencesChair of the Board of Directorscurrent2022 — presentLondon Area, United Kingdom
  3. Xap TherapeuticsChair of the Board of Directorscurrent2020 — presentCambridge, England, United Kingdom
  4. ERS GenomicsBoard Membercurrent2014 — presentDublin, Ireland
  5. SR One Capital ManagementVenture Partner2020 — 2025
  6. CRISPR TherapeuticsPresident & Chair Board of Directors2017 — 2023Zug, Switzerland
  7. CRISPR TherapeuticsChief Executive Officer2013 — 2017
  8. SanofiVP Head TSU Infectious Diseases Global R&D2012 — 2013Chilly-Mazarin, France
  9. Nabriva Therapeutics AGFounder and Chief Operating Officer2006 — 2012
  10. SandozDeputy Head Antibiotic Research Institute2003 — 2005
  11. Vienna BioCenterUniversity Professor2000 — 2003

Education

  1. NYU, Skirball Institute, NYC1999 — 2001
  2. St. Jude Children's Research Hospital, Memphis, TN1998 — 1999
  3. The Rockefeller University, NYC1996 — 1997
  4. Marburg UniversityMD1987 — 1992

Skills & more

Clinical Development22Infectious Diseases31Cell2Drug Discovery21Pharmaceutical Industry20In Vitro3Biotechnology21Biopharmaceuticals8Assay Development3Drug Development18Oncology6Clinical Trials7
+12 moreLifesciencesVaccinesProtein ChemistryClinical ResearchCTMSTechnology TransferCROCell BiologyMolecular BiologyLife SciencesBiochemistryCRO Management

From Rodger's professional profile.

Colleagues at SR One Capital Management

Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management

Network1

Deborah Harland
Partner at SR One Capital Management

Investors connected to Rodger in public investor directories — a warm-intro map.

Frequently asked questions

Where does Rodger Novak work?
Rodger Novak is Venture Partner at SR One Capital Management.
What check size does Rodger Novak write?
Rodger Novak typically writes checks of $500K – $5M.

Same school

Also attended Marburg University7

Jacqueline TerzievaManager People Excellence & Recruiting at Hannover Finanz GmbHVolker HeidtmannPartner at VidiaChristoph SporsPartner at Capiton AGJan-Henrik SupadyGeschäftsführender Gesellschafter, Diplom-Kaufmann at Liesner & Co. GmbHFabienne BerthetInvestor at Angels SantéKreske NickelsenPartner at kineo finance

+ 1 more

Shared employers

Also worked at SR One Capital Management28

Freya Svedberg-KeatingInvestor at MedicxiJake BauerVenture Partner at ARCH Venture PartnersAleks Radovic-MorenoPartner at Longwood FundRajeev DadooCOO & Managing Partner at SR One Capital ManagementJake NunnPartner at SR One Capital ManagementPhilip HabibHead of Capital Partnering at SR One Capital Management

+ 22 more

Also worked at CRISPR Therapeutics6

Briggs MorrisonEntrepreneur Partner at MPM BioImpactJerel DavisManaging Director at Versant VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONKurt von EmsterManaging Partner at AbingworthMaria FardisVenture Partner at Frazier Life SciencesTony HoInvestor at Pivotal Life Sciences

Also worked at Sanofi91

Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscoveryRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures

+ 85 more

Also worked at Nabriva Therapeutics AG1

Anja KoenigGlobal Head of NVF at Novartis Venture Fund